(Q37419690)

20 August 2017

Drug-induced liver injury following positive drug rechallenge (English)

1 reference

20 August 2017

Julie I Papay

1

1 reference

20 August 2017

Dawn Clines

2

1 reference

20 August 2017

Rezvan Rafi

3

1 reference

20 August 2017

Nancy Yuen

4

1 reference

20 August 2017

Susan D Britt

5

1 reference

20 August 2017

John S Walsh

6

1 reference

20 August 2017

Christine M Hunt

7

1 reference

20 August 2017

language of work or name

English

0 references

publication date

18 March 2009

1 reference

Regulatory Toxicology and Pharmacology

20 August 2017

1 reference

20 August 2017

54

1 reference

20 August 2017

1

1 reference

20 August 2017

84-90

1 reference

Drug-induced liver injury

20 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Monitoring and management of antituberculosis drug induced hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Accuracy of hepatic adverse drug reaction reporting in one English health region

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Clinical diagnostic scale: a useful tool in the evaluation of suspected hepatotoxic adverse drug reactions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Drug-Induced Liver Injury: An Analysis of 461 Incidences Submitted to the Spanish Registry Over a 10-Year Period

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Outcome of acute idiosyncratic drug-induced liver injury: Long-term follow-up in a hepatotoxicity registry

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

The role of scientific evidence of risks and benefits in determining risk management policies for medications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Mephenytoin disposition and serum bile acids as indices of hepatic function in chronic viral hepatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Effect of interferon alpha-ribavirin bitherapy on cytochrome P450 1A2 and 2D6 and N-acetyltransferase-2 activities in patients with chronic active hepatitis C.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Drug-induced liver injury: mechanisms and test systems.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Outcome and prognostic markers in severe drug-induced liver disease

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Effect of L-carnitine treatment for valproate-induced hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Recurrent immuno-allergic hepatitis related to amoxicillin-clavulanic acid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Allergic hepatitis induced by drugs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Zidovudine-induced mitochondrial disorder with massive liver steatosis, myopathy, lactic acidosis, and mitochondrial DNA depletion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Evaluation of cases of severe statin-related transaminitis within a large health maintenance organization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Causality assessment of adverse reactions to drugs--I. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Statins and liver toxicity: a meta-analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Fatal labetalol-induced hepatic injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Drug-induced liver injury in liver biopsies of the years 1981 and 1983, their prevalence and type of presentation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Assessing causality in drug-induced liver injury

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Drug-induced hepatotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Recognizing drug-induced liver injury: current problems, possible solutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Comparison of two clinical scales for causality assessment in hepatotoxicity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Acetylation rates and monthly liver function tests during one year of isoniazid preventive therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Post-halothane jaundice in relation to previous administration of halothane.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Cholinesterase inhibitors in the treatment of Alzheimer's disease: a comparison of tolerability and pharmacology.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

A double-blinded, randomized trial of hydrocortisone in acute hepatic failure. The Acute Hepatic Failure Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Liver transplantation for acute liver failure from drug induced liver injury in the United States

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Azathioprine hepatotoxicity after liver transplantation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

Jaundice with ondansetron

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YRTPH.2009.03.003

10.1016/J.YRTPH.2009.03.003

7 January 2021

Identifiers

DOI

1 reference

20 August 2017

1 reference